(-)-demecolcine decreases expression ISO RGD:736125 6480464 Demecolcine results in decreased expression of RRM2 mRNA CTD PMID:23649840 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:736125 6480464 o, p'-DDT results in decreased expression of RRM2 mRNA CTD PMID:18204070 1,1-dichloroethene increases expression ISO RGD:11248 6480464 vinylidene chloride results in increased expression of RRM2 mRNA CTD PMID:26682919 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:11248 6480464 Dinitrochlorobenzene results in increased expression of RRM2 mRNA CTD PMID:21404309 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RRM2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of RRM2 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:736125 6480464 Estradiol results in increased expression of RRM2 mRNA CTD PMID:16474171 more ... 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RRM2 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:736125 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RRM2 mRNA CTD PMID:17404688 17beta-estradiol affects expression ISO RGD:11248 6480464 Estradiol affects the expression of RRM2 mRNA CTD PMID:15598610 17beta-estradiol decreases expression ISO RGD:736125 6480464 Estradiol results in decreased expression of RRM2 mRNA CTD PMID:20106945 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RRM2 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:11248 6480464 2 more ... CTD PMID:25510870 , PMID:32352317 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:736125 6480464 2 more ... CTD PMID:19095052 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:11248 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11248 6480464 Tetrachlorodibenzodioxin results in decreased expression of RRM2 mRNA CTD PMID:19770486 , PMID:25270620 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RRM2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RRM2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11248 6480464 Tetrachlorodibenzodioxin affects the expression of RRM2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11248 6480464 Tetrachlorodibenzodioxin results in increased expression of RRM2 mRNA CTD PMID:15667827 , PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736125 6480464 Tetrachlorodibenzodioxin affects the expression of RRM2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736125 6480464 Tetrachlorodibenzodioxin results in decreased expression of RRM2 mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736125 6480464 Tetrachlorodibenzodioxin results in increased expression of RRM2 mRNA CTD PMID:20106945 2,4-diaminotoluene increases expression ISO RGD:11248 6480464 2, 4-diaminotoluene results in increased expression of RRM2 mRNA CTD PMID:20713471 2-butoxyethanol increases expression ISO RGD:11248 6480464 n-butoxyethanol results in increased expression of RRM2 mRNA CTD PMID:19812364 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of RRM2 mRNA CTD PMID:28522335 3-methylcholanthrene increases expression ISO RGD:11248 6480464 Methylcholanthrene results in increased expression of RRM2 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression ISO RGD:11248 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RRM2 mRNA CTD PMID:18648102 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:11248 6480464 Oxazolone results in increased expression of RRM2 mRNA CTD PMID:21404309 4-hydroxyphenyl retinamide increases expression ISO RGD:11248 6480464 Fenretinide results in increased expression of RRM2 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide decreases expression ISO RGD:11248 6480464 4-Nitroquinoline-1-oxide results in decreased expression of RRM2 mRNA CTD PMID:22561872 5-azacytidine multiple interactions ISO RGD:736125 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA CTD PMID:18720364 5-fluorouracil affects expression ISO RGD:736125 6480464 Fluorouracil affects the expression of RRM2 mRNA CTD PMID:15205334 , PMID:16584549 5-fluorouracil increases expression ISO RGD:736125 6480464 Fluorouracil results in increased expression of RRM2 mRNA CTD PMID:16709241 5-fluorouracil affects response to substance ISO RGD:736125 6480464 RRM2 protein affects the susceptibility to Fluorouracil CTD PMID:15548681 5-fluorouracil multiple interactions ISO RGD:736125 6480464 RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 5-fluorouracil decreases expression ISO RGD:736125 6480464 Fluorouracil results in decreased expression of RRM2 mRNA CTD PMID:16557594 , PMID:17039268 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RRM2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:11248 6480464 9 more ... CTD PMID:32553695 8-Br-cAMP decreases expression ISO RGD:736125 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RRM2 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of RRM2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RRM2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:736125 6480464 Acrylamide results in decreased expression of RRM2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:11248 6480464 Aflatoxin B1 results in decreased expression of RRM2 mRNA CTD PMID:19770486 aflatoxin B1 affects expression ISO RGD:736125 6480464 Aflatoxin B1 affects the expression of RRM2 protein CTD PMID:20106945 all-trans-retinoic acid decreases expression ISO RGD:736125 6480464 Tretinoin results in decreased expression of RRM2 mRNA CTD PMID:15498508 , PMID:33167477 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of RRM2 mRNA CTD PMID:30779732 antimycin A decreases expression ISO RGD:11248 6480464 Antimycin A results in decreased expression of RRM2 mRNA CTD PMID:19304788 antimycin A increases expression ISO RGD:736125 6480464 Antimycin A results in increased expression of RRM2 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:736125 6480464 aristolochic acid I results in decreased expression of RRM2 mRNA CTD PMID:33212167 aristolochic acid A increases expression ISO RGD:736125 6480464 aristolochic acid I results in increased expression of RRM2 mRNA, aristolochic acid I results in increased expression of RRM2 protein CTD PMID:33212167 arsenous acid decreases expression ISO RGD:736125 6480464 Arsenic Trioxide results in decreased expression of RRM2 mRNA, Arsenic Trioxide results in decreased expression of RRM2 protein CTD PMID:25419056 , PMID:26705709 azathioprine decreases expression ISO RGD:736125 6480464 Azathioprine results in decreased expression of RRM2 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:736125 6480464 Benzo(a)pyrene results in decreased expression of RRM2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:736125 6480464 Benzo(a)pyrene affects the methylation of RRM2 3' UTR, Benzo(a)pyrene affects the methylation of RRM2 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:11248 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:11248 6480464 Benzo(a)pyrene results in decreased expression of RRM2 mRNA CTD PMID:17942131 , PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736125 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:11248 6480464 benzo(b)fluoranthene results in increased expression of RRM2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:11248 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA CTD PMID:27858113 bicalutamide decreases expression ISO RGD:736125 6480464 bicalutamide results in decreased expression of RRM2 mRNA CTD PMID:15638997 biphenyl-4-amine multiple interactions ISO RGD:736125 6480464 TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RRM2 mRNA] CTD PMID:32905825 biphenyl-4-amine decreases expression ISO RGD:736125 6480464 4-biphenylamine results in decreased expression of RRM2 mRNA CTD PMID:32905825 bis(2-chloroethyl) sulfide decreases expression ISO RGD:736125 6480464 Mustard Gas results in decreased expression of RRM2 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:736125 6480464 bisphenol A results in increased expression of RRM2 mRNA CTD PMID:16474171 , PMID:31715268 bisphenol A multiple interactions ISO RGD:736125 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RRM2 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:736125 6480464 bisphenol A affects the expression of RRM2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:736125 6480464 bisphenol A results in decreased expression of RRM2 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RRM2 mRNA CTD PMID:30816183 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RRM2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RRM2 mRNA CTD PMID:25181051 , PMID:32528016 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of RRM2 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:736125 6480464 butyraldehyde results in decreased expression of RRM2 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:736125 6480464 Cadmium results in decreased expression of RRM2 mRNA CTD PMID:21120746 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RRM2 mRNA CTD PMID:25993096 cadmium dichloride decreases expression ISO RGD:736125 6480464 Cadmium Chloride results in decreased expression of RRM2 mRNA CTD PMID:26314618 caffeine multiple interactions ISO RGD:11248 6480464 Caffeine inhibits the reaction [Camptothecin results in increased expression of RRM2 mRNA], Caffeine inhibits the reaction [Camptothecin results in increased expression of RRM2 protein] CTD PMID:22403396 calcitriol decreases expression ISO RGD:736125 6480464 Calcitriol results in decreased expression of RRM2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:736125 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RRM2 mRNA CTD PMID:21592394 camptothecin increases expression ISO RGD:11248 6480464 Camptothecin results in increased expression of RRM2 mRNA, Camptothecin results in increased expression of RRM2 protein CTD PMID:22403396 camptothecin multiple interactions ISO RGD:11248 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Camptothecin results in increased expression of RRM2 protein] more ... CTD PMID:22403396 carbamazepine affects expression ISO RGD:736125 6480464 Carbamazepine affects the expression of RRM2 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:11248 6480464 Nanotubes, Carbon affects the expression of RRM2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:11248 6480464 Nanotubes, Carbon results in decreased expression of RRM2 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:11248 6480464 Nanotubes, Carbon analog results in increased expression of RRM2 mRNA CTD PMID:25554681 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of RRM2 mRNA CTD PMID:18500788 celastrol decreases expression ISO RGD:736125 6480464 celastrol results in decreased expression of RRM2 mRNA CTD PMID:17010675 choline multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 chromium(6+) affects expression ISO RGD:11248 6480464 chromium hexavalent ion affects the expression of RRM2 mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:11248 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA CTD PMID:27858113 ciclopirox decreases activity ISO RGD:11248 6480464 ciclopirox results in decreased activity of RRM2 protein CTD PMID:19589922 ciguatoxin CTX1B affects expression ISO RGD:11248 6480464 Ciguatoxins affects the expression of RRM2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:736125 6480464 Cisplatin results in increased expression of RRM2 mRNA CTD PMID:27594783 , PMID:33545341 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of RRM2 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:736125 6480464 BRCA1 mutant form promotes the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased activity of and results in increased phosphorylation of CHEK1 protein]]] more ... CTD PMID:21875941 cobalt atom multiple interactions ISO RGD:736125 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of RRM2 mRNA CTD PMID:23052192 cobalt dichloride decreases expression ISO RGD:736125 6480464 cobaltous chloride results in decreased expression of RRM2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:736125 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRM2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of RRM2 mRNA CTD PMID:20971185 , PMID:30911355 copper atom increases expression EXP 6480464 Copper results in increased expression of RRM2 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:736125 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRM2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of RRM2 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of RRM2 mRNA CTD PMID:22465980 coumarin affects phosphorylation ISO RGD:736125 6480464 coumarin affects the phosphorylation of RRM2 protein CTD PMID:35688186 coumestrol increases expression ISO RGD:736125 6480464 Coumestrol results in increased expression of RRM2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:736125 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:736125 6480464 Asbestos, Crocidolite results in decreased expression of RRM2 mRNA CTD PMID:29523930 CU-O LINKAGE decreases expression ISO RGD:736125 6480464 cupric oxide results in decreased expression of RRM2 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RRM2 mRNA CTD PMID:26577399 cyanocob(III)alamin multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 cycloheximide multiple interactions ISO RGD:11248 6480464 Cycloheximide inhibits the reaction [Progesterone results in increased expression of RRM2 mRNA] CTD PMID:22403396 cyclophosphamide multiple interactions ISO RGD:736125 6480464 RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 cyclosporin A decreases expression ISO RGD:11248 6480464 Cyclosporine results in decreased expression of RRM2 mRNA CTD PMID:17942131 , PMID:19770486 cyclosporin A affects expression ISO RGD:736125 6480464 Cyclosporine affects the expression of RRM2 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:736125 6480464 Cyclosporine results in decreased expression of RRM2 mRNA CTD PMID:19159671 more ... cytarabine increases expression ISO RGD:736125 6480464 Cytarabine results in increased expression of RRM2 mRNA CTD PMID:19194470 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of RRM2 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of RRM2 mRNA CTD PMID:23914054 dexamethasone increases expression ISO RGD:11248 6480464 Dexamethasone results in increased expression of RRM2 mRNA CTD PMID:22733784 diarsenic trioxide decreases expression ISO RGD:736125 6480464 Arsenic Trioxide results in decreased expression of RRM2 mRNA, Arsenic Trioxide results in decreased expression of RRM2 protein CTD PMID:25419056 , PMID:26705709 dibenz[a,h]anthracene increases expression ISO RGD:11248 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:11248 6480464 Dibutyl Phthalate results in decreased expression of RRM2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of RRM2 mRNA CTD PMID:21266533 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of RRM2 mRNA CTD PMID:21161181 diethyl maleate increases expression ISO RGD:736125 6480464 diethyl maleate results in increased expression of RRM2 mRNA CTD PMID:33545341 dioxygen multiple interactions ISO RGD:11248 6480464 [Iron co-treated with Oxygen] binds to RRM2 protein CTD PMID:16829694 dioxygen decreases expression ISO RGD:736125 6480464 Oxygen deficiency results in decreased expression of RRM2 mRNA CTD PMID:26516004 doxorubicin affects expression ISO RGD:736125 6480464 Doxorubicin affects the expression of RRM2 mRNA CTD PMID:15205334 doxorubicin decreases expression ISO RGD:736125 6480464 Doxorubicin results in decreased expression of RRM2 mRNA CTD PMID:29803840 , PMID:30031762 doxorubicin multiple interactions ISO RGD:736125 6480464 RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 Enterolactone multiple interactions ISO RGD:736125 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:11248 6480464 epoxiconazole results in decreased expression of RRM2 mRNA CTD PMID:35436446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of RRM2 mRNA CTD PMID:24412560 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of RRM2 mRNA CTD PMID:24412560 ethanol decreases expression ISO RGD:736125 6480464 Ethanol results in decreased expression of RRM2 mRNA CTD PMID:23378141 finasteride increases expression EXP 6480464 Finasteride results in increased expression of RRM2 mRNA CTD PMID:24136188 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of RRM2 mRNA CTD PMID:34044035 folic acid multiple interactions ISO RGD:736125 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of RRM2 mRNA CTD PMID:24657277 folic acid multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 fulvestrant multiple interactions ISO RGD:736125 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RRM2 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of RRM2 mRNA CTD PMID:25539665 gamma-tocopherol increases expression ISO RGD:11248 6480464 Tocopherols results in increased expression of RRM2 mRNA CTD PMID:17056531 gedunin decreases expression ISO RGD:736125 6480464 gedunin results in decreased expression of RRM2 mRNA CTD PMID:17010675 gemcitabine decreases response to substance ISO RGD:736125 6480464 RRM2 protein results in decreased susceptibility to Gemcitabine CTD PMID:14661056 gemcitabine multiple interactions ISO RGD:736125 6480464 [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of RRM2 protein CTD PMID:25189999 gemcitabine affects response to substance ISO RGD:736125 6480464 RRM2 protein affects the susceptibility to Gemcitabine CTD PMID:26894857 genistein increases expression ISO RGD:736125 6480464 Genistein results in increased expression of RRM2 mRNA CTD PMID:16474171 , PMID:20884965 genistein decreases expression ISO RGD:736125 6480464 Genistein results in decreased expression of RRM2 mRNA CTD PMID:22228119 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of RRM2 mRNA CTD PMID:24395379 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of RRM2 mRNA CTD PMID:26391144 glycine betaine multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 hydroxyurea decreases activity ISO RGD:11248 6480464 Hydroxyurea results in decreased activity of RRM2 protein CTD PMID:22403396 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RRM2 mRNA CTD PMID:22129741 iron atom multiple interactions ISO RGD:11248 6480464 [Iron co-treated with Oxygen] binds to RRM2 protein CTD PMID:16829694 iron(0) multiple interactions ISO RGD:11248 6480464 [Iron co-treated with Oxygen] binds to RRM2 protein CTD PMID:16829694 ivermectin decreases expression ISO RGD:736125 6480464 Ivermectin results in decreased expression of RRM2 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of RRM2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 leflunomide decreases expression ISO RGD:736125 6480464 leflunomide results in decreased expression of RRM2 mRNA CTD PMID:28988120 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of RRM2 mRNA CTD PMID:24136188 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of RRM2 mRNA CTD PMID:24136188 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of RRM2 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO RGD:736125 6480464 Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of RRM2 mRNA] CTD PMID:28070326 lipopolysaccharide affects expression ISO RGD:736125 6480464 Lipopolysaccharides affects the expression of RRM2 mRNA CTD PMID:28070326 lucanthone decreases expression ISO RGD:736125 6480464 Lucanthone results in decreased expression of RRM2 mRNA CTD PMID:21148553 LY294002 multiple interactions ISO RGD:11248 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Progesterone results in increased expression of RRM2 mRNA] CTD PMID:22403396 lycopene increases expression ISO RGD:736125 6480464 lycopene results in increased expression of RRM2 mRNA CTD PMID:16886892 MeIQx increases expression ISO RGD:736125 6480464 2-amino-3 more ... CTD PMID:20816883 metformin increases expression EXP 6480464 Metformin results in increased expression of RRM2 mRNA CTD PMID:31324951 methamphetamine decreases expression ISO RGD:736125 6480464 Methamphetamine results in decreased expression of RRM2 mRNA CTD PMID:25290377 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of RRM2 mRNA, Methamphetamine results in decreased expression of RRM2 protein CTD PMID:28341135 methotrexate affects expression ISO RGD:11248 6480464 Methotrexate affects the expression of RRM2 mRNA CTD PMID:18502557 methotrexate decreases expression ISO RGD:736125 6480464 Methotrexate results in decreased expression of RRM2 mRNA CTD PMID:24657277 methotrexate multiple interactions ISO RGD:736125 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of RRM2 mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:736125 6480464 Methyl Methanesulfonate results in increased expression of RRM2 mRNA CTD PMID:23649840 methylseleninic acid affects expression ISO RGD:736125 6480464 methylselenic acid affects the expression of RRM2 mRNA CTD PMID:14617803 miconazole increases expression ISO RGD:11248 6480464 Miconazole results in increased expression of RRM2 mRNA CTD PMID:27462272 mifepristone multiple interactions ISO RGD:11248 6480464 7-hydroxystaurosporine promotes the reaction [Mifepristone inhibits the reaction [Progesterone results in increased expression of RRM2 protein]] more ... CTD PMID:22403396 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:11248 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of RRM2 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium decreases expression ISO RGD:11248 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RRM2 mRNA CTD PMID:17475336 N-methyl-4-phenylpyridinium decreases expression ISO RGD:736125 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RRM2 mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:736125 6480464 Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA CTD PMID:26921499 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:736125 6480464 [[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form] more ... CTD PMID:26921499 N-nitrosodiethylamine multiple interactions ISO RGD:11248 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RRM2 mRNA CTD PMID:22129741 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of RRM2 mRNA CTD PMID:19638242 N-nitrosodiethylamine increases expression ISO RGD:11248 6480464 Diethylnitrosamine results in increased expression of RRM2 mRNA CTD PMID:17854601 N-Nitrosopyrrolidine decreases expression ISO RGD:736125 6480464 N-Nitrosopyrrolidine results in decreased expression of RRM2 mRNA CTD PMID:32234424 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of RRM2 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:736125 6480464 Nickel results in increased expression of RRM2 mRNA CTD PMID:25583101 niclosamide decreases expression ISO RGD:736125 6480464 Niclosamide results in decreased expression of RRM2 mRNA CTD PMID:28284560 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of RRM2 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RRM2 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RRM2 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:11248 6480464 Ozone results in increased expression of RRM2 mRNA CTD PMID:19555225 ozone multiple interactions ISO RGD:11248 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RRM2 mRNA more ... CTD PMID:25658374 , PMID:34911549 ozone decreases expression ISO RGD:11248 6480464 Ozone results in decreased expression of RRM2 mRNA CTD PMID:24336422 paclitaxel multiple interactions ISO RGD:736125 6480464 RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] CTD PMID:16896004 palbociclib decreases expression ISO RGD:736125 6480464 palbociclib results in decreased expression of RRM2 mRNA CTD PMID:22869556 paracetamol decreases expression ISO RGD:11248 6480464 Acetaminophen results in decreased expression of RRM2 mRNA CTD PMID:17942131 paracetamol decreases expression ISO RGD:736125 6480464 Acetaminophen results in decreased expression of RRM2 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:11248 6480464 Acetaminophen results in increased expression of RRM2 mRNA CTD PMID:24126418 PCB138 multiple interactions ISO RGD:11248 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:736125 6480464 perfluoro-n-nonanoic acid results in decreased expression of RRM2 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO RGD:736125 6480464 perfluorooctanoic acid results in decreased expression of RRM2 mRNA CTD PMID:23978341 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of RRM2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:11248 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RRM2 mRNA more ... CTD PMID:19482888 more ... phenobarbital increases expression ISO RGD:11248 6480464 Phenobarbital results in increased expression of RRM2 mRNA CTD PMID:19482888 more ... phenobarbital affects expression ISO RGD:736125 6480464 Phenobarbital affects the expression of RRM2 mRNA CTD PMID:19159669 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of RRM2 mRNA CTD PMID:29877212 phytoestrogen increases expression ISO RGD:736125 6480464 Phytoestrogens results in increased expression of RRM2 mRNA CTD PMID:18310284 picoxystrobin increases expression ISO RGD:736125 6480464 picoxystrobin results in increased expression of RRM2 mRNA CTD PMID:33512557 pinosylvin decreases expression ISO RGD:736125 6480464 pinosylvin results in decreased expression of RRM2 mRNA CTD PMID:23333577 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of RRM2 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:11248 6480464 pirinixic acid results in increased expression of RRM2 mRNA CTD PMID:18301758 more ... piroxicam decreases expression ISO RGD:736125 6480464 Piroxicam results in decreased expression of RRM2 mRNA CTD PMID:21858171 potassium dichromate increases expression ISO RGD:736125 6480464 Potassium Dichromate results in increased expression of RRM2 protein CTD PMID:23718831 progesterone decreases expression ISO RGD:736125 6480464 Progesterone results in decreased expression of RRM2 mRNA CTD PMID:21795739 progesterone multiple interactions ISO RGD:11248 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Progesterone results in increased expression of RRM2 mRNA] more ... CTD PMID:22403396 progesterone increases expression ISO RGD:736125 6480464 Progesterone results in increased expression of RRM2 mRNA CTD PMID:18070364 progesterone increases expression ISO RGD:11248 6480464 Progesterone results in increased expression of RRM2 mRNA, Progesterone results in increased expression of RRM2 protein CTD PMID:22403396 progesterone multiple interactions ISO RGD:736125 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RRM2 mRNA CTD PMID:17404688 propanal decreases expression ISO RGD:736125 6480464 propionaldehyde results in decreased expression of RRM2 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:11248 6480464 propiconazole results in increased expression of RRM2 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:736125 6480464 Quercetin results in decreased expression of RRM2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:736125 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of RRM2 mRNA CTD PMID:19167446 resveratrol decreases expression ISO RGD:736125 6480464 resveratrol results in decreased expression of RRM2 mRNA CTD PMID:15767336 rotenone decreases expression ISO RGD:11248 6480464 Rotenone results in decreased expression of RRM2 mRNA CTD PMID:19304788 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RRM2 mRNA, Rotenone results in decreased expression of RRM2 protein CTD PMID:28374803 , PMID:35544339 rotenone increases expression EXP 6480464 Rotenone results in increased expression of RRM2 mRNA CTD PMID:19013527 serpentine asbestos increases expression ISO RGD:736125 6480464 Asbestos, Serpentine results in increased expression of RRM2 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:736125 6480464 Silicon Dioxide analog results in increased expression of RRM2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:11248 6480464 Silicon Dioxide results in increased expression of RRM2 mRNA CTD PMID:29341224 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of RRM2 mRNA CTD PMID:22431001 silicon dioxide decreases expression ISO RGD:736125 6480464 Silicon Dioxide analog results in decreased expression of RRM2 mRNA, Silicon Dioxide results in decreased expression of RRM2 mRNA CTD PMID:23806026 , PMID:25351596 sodium arsenite decreases expression ISO RGD:736125 6480464 sodium arsenite results in decreased expression of RRM2 mRNA, sodium arsenite results in decreased expression of RRM2 protein CTD PMID:20371982 more ... sodium arsenite affects expression ISO RGD:736125 6480464 sodium arsenite affects the expression of RRM2 mRNA CTD PMID:29301061 , PMID:34032870 sodium arsenite increases expression ISO RGD:736125 6480464 sodium arsenite results in increased expression of RRM2 mRNA CTD PMID:28595984 sodium dichromate increases expression ISO RGD:11248 6480464 sodium bichromate results in increased expression of RRM2 mRNA CTD PMID:22155349 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of RRM2 mRNA CTD PMID:22110744 Soman increases expression EXP 6480464 Soman results in increased expression of RRM2 mRNA CTD PMID:19281266 sulindac sulfide decreases expression ISO RGD:736125 6480464 sulindac sulfide results in decreased expression of RRM2 mRNA CTD PMID:12734198 sunitinib decreases expression ISO RGD:736125 6480464 Sunitinib results in decreased expression of RRM2 mRNA CTD PMID:31533062 tamibarotene affects expression ISO RGD:736125 6480464 tamibarotene affects the expression of RRM2 mRNA CTD PMID:15498508 tebufenpyrad increases expression ISO RGD:736125 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RRM2 mRNA CTD PMID:33512557 testosterone decreases expression ISO RGD:736125 6480464 Testosterone results in decreased expression of RRM2 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RRM2 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:11248 6480464 Testosterone deficiency results in decreased expression of RRM2 mRNA CTD PMID:33848595 testosterone multiple interactions ISO RGD:736125 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RRM2 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:11248 6480464 Carbon Tetrachloride affects the expression of RRM2 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11248 6480464 Carbon Tetrachloride results in increased expression of RRM2 mRNA CTD PMID:27339419 more ... tetraphene multiple interactions ISO RGD:11248 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA CTD PMID:27858113 thalidomide multiple interactions ISO RGD:736125 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA CTD PMID:18720364 thapsigargin decreases expression ISO RGD:736125 6480464 Thapsigargin results in decreased expression of RRM2 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RRM2 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:11248 6480464 titanium dioxide results in increased expression of RRM2 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of RRM2 mRNA CTD PMID:30012374 titanium dioxide affects expression ISO RGD:11248 6480464 titanium dioxide affects the expression of RRM2 mRNA CTD PMID:17656681 tocopherol increases expression ISO RGD:11248 6480464 Tocopherols results in increased expression of RRM2 mRNA CTD PMID:17056531 toluene 2,4-diisocyanate increases expression ISO RGD:11248 6480464 Toluene 2, 4-Diisocyanate results in increased expression of RRM2 mRNA CTD PMID:21404309 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RRM2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RRM2 mRNA CTD PMID:25729387 trans-pinosylvin decreases expression ISO RGD:736125 6480464 pinosylvin results in decreased expression of RRM2 mRNA CTD PMID:23333577 Tributyltin oxide decreases expression ISO RGD:11248 6480464 bis(tri-n-butyltin)oxide results in decreased expression of RRM2 mRNA CTD PMID:17942131 Tributyltin oxide decreases phosphorylation ISO RGD:11248 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of RRM2 protein CTD PMID:22174045 triclosan decreases expression ISO RGD:736125 6480464 Triclosan results in decreased expression of RRM2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:11248 6480464 trimellitic anhydride results in increased expression of RRM2 mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:11248 6480464 triptonide results in decreased expression of RRM2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:736125 6480464 troglitazone results in decreased expression of RRM2 mRNA CTD PMID:19140230 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of RRM2 mRNA CTD PMID:24136188 trovafloxacin decreases expression ISO RGD:11248 6480464 trovafloxacin results in decreased expression of RRM2 mRNA CTD PMID:35537566 Tungsten carbide multiple interactions ISO RGD:736125 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of RRM2 mRNA CTD PMID:23052192 tunicamycin decreases expression ISO RGD:736125 6480464 Tunicamycin results in decreased expression of RRM2 mRNA CTD PMID:22378314 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of RRM2 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:11248 6480464 Valproic Acid results in decreased expression of RRM2 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:736125 6480464 Valproic Acid affects the expression of RRM2 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:736125 6480464 Valproic Acid results in increased methylation of RRM2 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:736125 6480464 Valproic Acid results in decreased expression of RRM2 mRNA CTD PMID:19101580 vincaleukoblastine affects response to substance ISO RGD:736125 6480464 RRM2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincristine decreases expression ISO RGD:736125 6480464 Vincristine results in decreased expression of RRM2 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO RGD:11248 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA CTD PMID:33549593 zoledronic acid decreases expression ISO RGD:736125 6480464 zoledronic acid results in decreased expression of RRM2 mRNA CTD PMID:24714768